The flavor giant is shrinking on purpose, and its largest revenue driver is the latest piece to go.
International Flavors & Fragrances is selling its food-ingredients business to private equity firm CVC Capital Partners in a deal worth $4.3 billion including debt. The move is IFF’s latest push to boost profitability, shedding a division that generated nearly $3.28 billion in sales last year while the company digests a run of past acquisitions.
Picture this. A company famous for making perfumes smell better and helping gelato taste richer just handed off the single biggest chunk of its revenue. Not because it was drowning, but because it wants to get leaner, sharper, and a whole lot more profitable. That is a confident move, and it tells you everything about where IFF thinks the money is.
What Happened
IFF announced on Friday that it agreed to sell its food-ingredients unit to CVC Capital Partners, with the deal valuing the division at $4.3 billion including debt. IFF is not walking away completely. It will keep a 10% stake in the business, partly to keep the two sides cooperating and partly so IFF shareholders can still cash in if CVC grows the division’s value. Both companies expect to close the deal by the middle of next year.
The Backstory
New York-based IFF is a roughly $20 billion company that makes everything from perfume scents to food ingredients that help with digestion. The food-ingredients arm churned out emulsifiers that make food production more efficient, plus sweeteners and even paste for gelato.
Here is the twist. This was IFF’s biggest division by revenue, but it was cooling off. Sales fell year over year in 2025, and the company recently wrote down the value of the unit. First-quarter revenue did tick back up, so it is not all gloom, but the trend gave IFF a reason to move.
This sale is the next chapter in a longer cleanup story. After merging with DuPont’s nutrition business in 2021, IFF has been steadily selling pieces off. Last year it offloaded its dietary-supplements business for up to $2.85 billion including debt to French producer Roquette. In March, it sold its soy crush and lecithin business to crop trader Bunge for an undisclosed sum.
The Plan
The logic is simple. Sell the big, slowing, capital-heavy division to a buyer that can run it harder, pocket the proceeds, and sharpen the rest of the company around higher-margin work. Keeping that 10% slice means IFF still rides any upside CVC creates without carrying the full operational weight. For the buyer, CVC is no stranger to this space. The Luxembourg-based firm oversees about €209 billion in assets, equivalent to more than $243 billion, and is well known for chemicals plays like Brazilian lubricants maker Moove and Dutch chemicals producer AnQore. This week it also sold its minority stake in Spain’s Naturgy Energy for close to $3.6 billion, so the dealmaking machine is clearly humming.
The Business Model Angle
This is the classic “buy big, then refocus” playbook, and it is worth studying. Companies often bulk up through splashy acquisitions, realize the combined entity is sprawling and hard to value, then start pruning to chase margins over sheer size. Markets frequently slap a “conglomerate discount” on businesses that do too many unrelated things, and selling the slowest grower can unlock value the parent could never squeeze out alone.
The smart wrinkle here is the retained 10% stake. Instead of a clean exit, IFF keeps skin in the game. That aligns incentives, keeps the supply relationship friendly, and lets shareholders benefit if CVC’s operators outperform. The lesson for founders and operators: bigger is not automatically better. Focus, cash flow, and the right owner for each asset can matter more than holding everything under one roof.
The Risk
Let’s not wrap this in a bow. Selling your single largest revenue line is a bold bet, and the timing raises eyebrows. IFF just wrote down this unit, which means it could be selling near a low point rather than a high. If CVC turns the division around, IFF only captures 10% of that comeback. There is also execution risk in getting the deal closed by the middle of next year.
And here is the strategic tension worth sitting with. While IFF slims down, rival Ingredion is trying to bulk up, currently in talks to buy U.K. ingredients maker Tate & Lyle with a takeover proposal worth about $3.7 billion. Two competitors, two opposite strategies. Only one playbook can be right for this market, and we will not know which for a while. If you want the original reporting, the full story is in The Wall Street Journal.
Quick Questions
Why is IFF selling its food-ingredients business?
To boost profitability. It was the biggest division by revenue, but sales fell in 2025 and the unit was recently written down, so IFF is cashing out and refocusing.
How much is the IFF and CVC deal worth?
The deal values the food-ingredients division at $4.3 billion including debt. IFF keeps a 10% stake in the business.
Who is CVC Capital Partners?
A Luxembourg-based private equity firm managing about €209 billion in assets, more than $243 billion. It is known for chemicals investments like Moove and AnQore.
When will the IFF CVC deal close?
Both companies expect it to close by the middle of next year.
The Bottom Line
Growth and focus are not the same thing, and the best operators know when to trade one for the other. IFF is betting that a smaller, sharper company is worth more than a sprawling one, and it is keeping a 10% stake so it does not miss the upside if it is right. The takeaway for founders: review your portfolio like a buyer would, and be willing to sell your biggest thing if it is no longer your best thing. Want more deal breakdowns like this one? Dive into the Business Model Analyst blog.
